Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1998 Aug;79(2):161–164. doi: 10.1136/adc.79.2.161

Height and weight pattern up to 20 years after treatment for acute lymphoblastic leukaemia

N Birkebak, N Clausen
PMCID: PMC1717656  PMID: 9797600

Abstract

OBJECTIVE—To assess height and body mass index standard deviation scores up to 20 years after treatment for acute lymphoblastic leukaemia (ALL).
SUBJECTS AND METHODS—Height and body mass index standard deviation scores were measured in 33 patients (14 boys and 19 girls) with childhood ALL at diagnosis, after the end of treatment, at final height, and at follow up 10-20 years (median, 16.2) after diagnosis. Eleven patients were treated with chemotherapy only and 22 patients were treated with chemotherapy and cranial irradiation.
RESULTS—In the chemotherapy only group, height standard deviation scores were the same at follow up as at diagnosis, but there was a significant decrease in height standard deviation scores during treatment. Mean body mass index standard deviation scores increased steadily from the start of treatment until final height and continued to increase from final height until follow up. In the cranially irradiated group, mean height standard deviation scores decreased steadily from the start of treatment until follow up. Mean body mass index standard deviation scores increased continuously from the start of treatment until final height and from final height until follow up.
CONCLUSION—Chemotherapy combined with cranial irradiation and chemotherapy alone might be persisting risk factors for obesity even after final height has been attained in patients treated for childhood ALL. Chemotherapy is a risk factor for reduced final height only when administered in combination with cranial irradiation. These problems need to be recognised and dealt with at follow up examination.



Full Text

The Full Text of this article is available as a PDF (101.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Birkebaek N. H., Fisker S., Clausen N., Tuovinen V., Sindet-Pedersen S., Christiansen J. S. Growth and endocrinological disorders up to 21 years after treatment for acute lymphoblastic leukemia in childhood. Med Pediatr Oncol. 1998 Jun;30(6):351–356. doi: 10.1002/(sici)1096-911x(199806)30:6<351::aid-mpo9>3.0.co;2-d. [DOI] [PubMed] [Google Scholar]
  2. Broomhall J., May R., Lilleyman J. S., Milner R. D. Height and lymphoblastic leukaemia. Arch Dis Child. 1983 Apr;58(4):300–301. doi: 10.1136/adc.58.4.300. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Clayton P. E., Shalet S. M., Morris-Jones P. H., Price D. A. Growth in children treated for acute lymphoblastic leukaemia. Lancet. 1988 Feb 27;1(8583):460–462. doi: 10.1016/s0140-6736(88)91246-9. [DOI] [PubMed] [Google Scholar]
  4. Dacou-Voutetakis C., Kitra V., Grafakos S., Polychronopoulou S., Drakopoulou M., Haidas S. Auxologic data and hormonal profile in long-term survivors of childhood acute lymphoid leukemia. Am J Pediatr Hematol Oncol. 1993 Aug;15(3):277–283. [PubMed] [Google Scholar]
  5. Didi M., Didcock E., Davies H. A., Ogilvy-Stuart A. L., Wales J. K., Shalet S. M. High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood. J Pediatr. 1995 Jul;127(1):63–67. doi: 10.1016/s0022-3476(95)70258-x. [DOI] [PubMed] [Google Scholar]
  6. Holm K., Nysom K., Hertz H., Müller J. Normal final height after treatment for acute lymphoblastic leukemia without irradiation. Acta Paediatr. 1994 Dec;83(12):1287–1290. doi: 10.1111/j.1651-2227.1994.tb13018.x. [DOI] [PubMed] [Google Scholar]
  7. Kirk J. A., Raghupathy P., Stevens M. M., Cowell C. T., Menser M. A., Bergin M., Tink A., Vines R. H., Silink M. Growth failure and growth-hormone deficiency after treatment for acute lymphoblastic leukaemia. Lancet. 1987 Jan 24;1(8526):190–193. doi: 10.1016/s0140-6736(87)90004-3. [DOI] [PubMed] [Google Scholar]
  8. Moëll C., Garwicz S. High-dose methotrexate causes short-term suppression of growth in rabbits. Acta Paediatr. 1995 Nov;84(11):1237–1240. doi: 10.1111/j.1651-2227.1995.tb13540.x. [DOI] [PubMed] [Google Scholar]
  9. Moëll C., Marky I., Hovi L., Kristinsson J., Rix M., Moe P. J., Garwicz S. Cerebral irradiation causes blunted pubertal growth in girls treated for acute leukemia. Med Pediatr Oncol. 1994;22(6):375–379. doi: 10.1002/mpo.2950220604. [DOI] [PubMed] [Google Scholar]
  10. Odame I., Reilly J. J., Gibson B. E., Donaldson M. D. Patterns of obesity in boys and girls after treatment for acute lymphoblastic leukaemia. Arch Dis Child. 1994 Aug;71(2):147–149. doi: 10.1136/adc.71.2.147. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Pui C. H. Childhood leukemias. N Engl J Med. 1995 Jun 15;332(24):1618–1630. doi: 10.1056/NEJM199506153322407. [DOI] [PubMed] [Google Scholar]
  12. Robison L. L., Nesbit M. E., Jr, Sather H. N., Meadows A. T., Ortega J. A., Hammond G. D. Height of children successfully treated for acute lymphoblastic leukemia: a report from the Late Effects Study Committee of Childrens Cancer Study Group. Med Pediatr Oncol. 1985;13(1):14–21. doi: 10.1002/mpo.2950130105. [DOI] [PubMed] [Google Scholar]
  13. Rolland-Cachera M. F., Cole T. J., Sempé M., Tichet J., Rossignol C., Charraud A. Body Mass Index variations: centiles from birth to 87 years. Eur J Clin Nutr. 1991 Jan;45(1):13–21. [PubMed] [Google Scholar]
  14. Sainsbury C. P., Newcombe R. G., Hughes I. A. Weight gain and height velocity during prolonged first remission from acute lymphoblastic leukaemia. Arch Dis Child. 1985 Sep;60(9):832–836. doi: 10.1136/adc.60.9.832. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Schell M. J., Ochs J. J., Schriock E. A., Carter M. A method of predicting adult height and obesity in long-term survivors of childhood acute lymphoblastic leukemia. J Clin Oncol. 1992 Jan;10(1):128–133. doi: 10.1200/JCO.1992.10.1.128. [DOI] [PubMed] [Google Scholar]
  16. Schriock E. A., Schell M. J., Carter M., Hustu O., Ochs J. J. Abnormal growth patterns and adult short stature in 115 long-term survivors of childhood leukemia. J Clin Oncol. 1991 Mar;9(3):400–405. doi: 10.1200/JCO.1991.9.3.400. [DOI] [PubMed] [Google Scholar]
  17. Sklar C., Mertens A., Walter A., Mitchell D., Nesbit M., O'Leary M., Hutchinson R., Meadows A., Robison L. Final height after treatment for childhood acute lymphoblastic leukemia: comparison of no cranial irradiation with 1800 and 2400 centigrays of cranial irradiation. J Pediatr. 1993 Jul;123(1):59–64. doi: 10.1016/s0022-3476(05)81537-9. [DOI] [PubMed] [Google Scholar]
  18. Uruena M., Stanhope R., Chessells J. M., Leiper A. D. Impaired pubertal growth in acute lymphoblastic leukaemia. Arch Dis Child. 1991 Dec;66(12):1403–1407. doi: 10.1136/adc.66.12.1403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Van Dongen-Melman J. E., Hokken-Koelega A. C., Hählen K., De Groot A., Tromp C. G., Egeler R. M. Obesity after successful treatment of acute lymphoblastic leukemia in childhood. Pediatr Res. 1995 Jul;38(1):86–90. doi: 10.1203/00006450-199507000-00015. [DOI] [PubMed] [Google Scholar]
  20. Zee P., Chen C. H. Prevalence of obesity in children after therapy for acute lymphoblastic leukemia. Am J Pediatr Hematol Oncol. 1986 Winter;8(4):294–299. doi: 10.1097/00043426-198624000-00005. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES